Ketamine Treatment for Bipolar Depression
Latest medical review on: July 15th, 2026. Medically reviewed by Instructor in Psychiatry at Harvard Medical School and Lumin Health Co-founder, Chief Medical Officer Dr. Ben Yudkoff.
Ketamine therapy is an evidence-based, off-label treatment for bipolar depression that may begin easing symptoms within hours to days — not the weeks typical of standard medications. At Lumin Health, it's provided as intramuscular (IM) ketamine, administered by psychiatric clinicians in a private, calm setting.
If you're living with bipolar depression — the crushing lows that follow the highs, the exhaustion of cycling between states — and conventional treatments haven't brought enough relief, you're not out of options. Because bipolar depression carries a unique set of risks, careful psychiatric screening and monitoring matter here more than ever. This page walks through what the research shows, how treatment works, and what it costs, so you can decide whether it may be a fit.
What the research shows about ketamine for bipolar depression
Evidence from randomized controlled trials on ketamine and bipolar depression
Ketamine for bipolar depression has been studied in randomized controlled trials. In the first (Archives of General Psychiatry, 2010), a single dose of intravenous ketamine produced rapid antidepressant effects in treatment-resistant bipolar depression compared with placebo, with effects visible within hours and lasting days. A replication trial (Biological Psychiatry, 2012) confirmed the finding. A 2023 systematic review and meta-analysis pooling the available trials found significant antidepressant effects from single and serial ketamine infusions — though, as with any treatment, it doesn't work for everyone.
Most of this research used intravenous (IV) ketamine. Lumin Health provides the same medicine as an intramuscular (IM) injection — a faster, more comfortable route than a long IV session.
Ketamine for bipolar depression has been studied in randomized controlled trials. In the first (Archives of General Psychiatry, 2010), a single dose of intravenous ketamine produced rapid antidepressant effects in treatment-resistant bipolar depression compared with placebo, with effects visible within hours and lasting days. A replication trial (Biological Psychiatry, 2012) confirmed the finding. A 2023 systematic review and meta-analysis pooling the available trials found significant antidepressant effects from single and serial ketamine infusions — though, as with any treatment, it doesn't work for everyone.
Most of this research used intravenous (IV) ketamine. Lumin Health provides the same medicine as an intramuscular (IM) injection — a faster, more comfortable route than a long IV session.
Why bipolar depression calls for extra care in ketamine treatment
Bipolar depression is a complicated condition to treat — many treatments that can relieve depression may also trigger a manic episode, and ketamine is no exception. Using ketamine for bipolar depression requires extra caution that may not be necessary for major depressive disorder. A 2023 meta-analysis reported affective switch rates (a shift toward mania or hypomania) of roughly 2-3% across studies, though individual risk varies. Staying on a mood-stabilizing medication if you've been prescribed one, and staying in close contact with your care team — and family or chosen family — is key to building layers of safety. Doing so may help identify manic or hypomanic symptoms early and protect against their impact.
Bipolar depression is a complicated condition to treat — many treatments that can relieve depression may also trigger a manic episode, and ketamine is no exception. Using ketamine for bipolar depression requires extra caution that may not be necessary for major depressive disorder. A 2023 meta-analysis reported affective switch rates (a shift toward mania or hypomania) of roughly 2-3% across studies, though individual risk varies. Staying on a mood-stabilizing medication if you've been prescribed one, and staying in close contact with your care team — and family or chosen family — is key to building layers of safety. Doing so may help identify manic or hypomanic symptoms early and protect against their impact.
If you’d like to explore how ketamine therapy or esketamine (Spravato) treatment could help you, book a complimentary consultation below. We look forward to speaking with you.
How ketamine works in a brain stuck in depression
Neuroplasticity: helping the brain form new connections
Ketamine acts on the brain's NMDA receptors, part of the glutamate system — the chemistry the brain uses for learning and change. This triggers a period of heightened neuroplasticity: a window in which the brain can more easily form new connections. Your brain isn't broken — it may be stuck, replaying patterns that keep depression locked in place. Ketamine may help loosen those patterns so new ones can form. Read more about ketamine and neuroplasticity.
Ketamine acts on the brain's NMDA receptors, part of the glutamate system — the chemistry the brain uses for learning and change. This triggers a period of heightened neuroplasticity: a window in which the brain can more easily form new connections. Your brain isn't broken — it may be stuck, replaying patterns that keep depression locked in place. Ketamine may help loosen those patterns so new ones can form. Read more about ketamine and neuroplasticity.
Glutamate, mood, and the depression cycle
By modulating glutamate signaling, ketamine may quiet the circuitry that keeps depressive episodes locked in and support mood regulation. This is part of why relief, when it comes, often arrives fast — the mechanism differs from standard antidepressants, which act gradually on serotonin, norepinephrine, and dopamine.
By modulating glutamate signaling, ketamine may quiet the circuitry that keeps depressive episodes locked in and support mood regulation. This is part of why relief, when it comes, often arrives fast — the mechanism differs from standard antidepressants, which act gradually on serotonin, norepinephrine, and dopamine.
IM ketamine vs. esketamine (Spravato) for bipolar depression
Neuroplasticity: helping the brain form new connections
Esketamine (Spravato) is FDA-approved for treatment-resistant depression and for major depressive disorder with acute suicidal ideation — but these indications are for unipolar depression, not bipolar depression. Patients with bipolar disorder were typically excluded from the esketamine clinical trials, and Spravato is not an indicated option for bipolar depression.
For bipolar depression, Lumin Health clinicians use intramuscular (IM) ketamine: an off-label application of a medicine that's been in use for over 50 years, supported by randomized controlled trials in bipolar depression specifically. Off-label prescribing is common and legal when supported by clinical research — though it does affect insurance coverage, which we explain below.
Learn more about the differences between ketamine and esketamine.
Esketamine (Spravato) is FDA-approved for treatment-resistant depression and for major depressive disorder with acute suicidal ideation — but these indications are for unipolar depression, not bipolar depression. Patients with bipolar disorder were typically excluded from the esketamine clinical trials, and Spravato is not an indicated option for bipolar depression.
For bipolar depression, Lumin Health clinicians use intramuscular (IM) ketamine: an off-label application of a medicine that's been in use for over 50 years, supported by randomized controlled trials in bipolar depression specifically. Off-label prescribing is common and legal when supported by clinical research — though it does affect insurance coverage, which we explain below.
Learn more about the differences between ketamine and esketamine.
Scientific literature supporting the use of ketamine for bipolar depression
- Diazgranados et al., A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression — Arch Gen Psychiatry, 2010.
- Zarate et al., Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial — Biol Psychiatry, 2012.
- Gałuszko-Węgielnik et al., Efficacy of Ketamine in bipolar depression: focus on anhedonia — Psychiatr Danub, 2019.
- Nunez et al., An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis — Brain Sci, 2023.
Insurance coverage and the cost of ketamine for bipolar depression
Why coverage for bipolar depression is limited
Because ketamine doesn't have an FDA-approved (on-label) indication for bipolar depression, most commercial insurers don't cover IM ketamine for it. We're transparent about this up front: IM ketamine at Lumin Health is $500 per session, and we provide a Superbill — an itemized receipt — that patients with out-of-network PPO benefits can submit for potential partial reimbursement. Full details on our ketamine treatment cost page.
Because ketamine doesn't have an FDA-approved (on-label) indication for bipolar depression, most commercial insurers don't cover IM ketamine for it. We're transparent about this up front: IM ketamine at Lumin Health is $500 per session, and we provide a Superbill — an itemized receipt — that patients with out-of-network PPO benefits can submit for potential partial reimbursement. Full details on our ketamine treatment cost page.
Making treatment accessible
We offer payment structures designed to minimize out-of-pocket spend while maximizing the chance treatment succeeds. Our team will walk you through every option during your free consultation — check your plan on our insurance page or ask us directly.
We offer payment structures designed to minimize out-of-pocket spend while maximizing the chance treatment succeeds. Our team will walk you through every option during your free consultation — check your plan on our insurance page or ask us directly.
What to expect during ketamine treatment for bipolar depression
Personalized Treatment Plans
It starts with a free consultation. Our psychiatric team — psychiatrists and psychiatric nurse practitioners, specifically trained in ketamine and esketamine — will review your symptoms, history, and goals, and build a plan around you. For most people, a course of 6-10 sessions over 3-5 weeks is enough to see meaningful results.
It starts with a free consultation. Our psychiatric team — psychiatrists and psychiatric nurse practitioners, specifically trained in ketamine and esketamine — will review your symptoms, history, and goals, and build a plan around you. For most people, a course of 6-10 sessions over 3-5 weeks is enough to see meaningful results.
Safe and Comfortable Environment
Every session takes place in a private room with psychiatric care throughout. You'll be monitored the entire time, and our staff will make sure you feel settled, safe, and unhurried.
Every session takes place in a private room with psychiatric care throughout. You'll be monitored the entire time, and our staff will make sure you feel settled, safe, and unhurried.
Positive Effects and Follow-Up
After the initial sessions, many patients describe a lifting of the depressive weight — more energy, more room to engage with life, a steadier mood. We track your progress together and watch for any sign of mood cycling, adjusting the plan as needed, with lasting relief as the goal.
After the initial sessions, many patients describe a lifting of the depressive weight — more energy, more room to engage with life, a steadier mood. We track your progress together and watch for any sign of mood cycling, adjusting the plan as needed, with lasting relief as the goal.
How fast does ketamine work for bipolar depression?
Faster than most treatments you may have tried. In clinical trials, symptom relief often appeared within hours to days of a dose. How long relief lasts varies, which is why treatment is typically a series of sessions rather than one.
Can ketamine treat bipolar depression?
There is evidence in the scientific literature that, for some people, ketamine can meaningfully reduce bipolar depression symptoms — including randomized controlled trials of single and repeated dosing. It doesn't work for everyone, and the need for mood monitoring makes careful clinician oversight especially important. Our team will be honest with you about whether it's a fit.
Is ketamine FDA-approved for bipolar depression?
No. Ketamine's only FDA-approved use is anesthesia; its use for bipolar depression is off-label, supported by randomized controlled trials and a growing research base. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation — but these indications are for unipolar depression, not bipolar depression.
Does ketamine risk triggering mania in bipolar disorder?
That's an important concern. Some treatments that relieve bipolar depression can also trigger a manic or hypomanic episode, and ketamine is no exception. A 2023 meta-analysis reported affective switch rates of roughly 2-3% across studies. Careful psychiatric screening, staying on a mood stabilizer if you've been prescribed one, and close monitoring during treatment all help manage this risk. Our clinicians will talk through your specific risk profile with you.
What about suicidal ideation (SI)? Can ketamine help with that?
Yes, ketamine has demonstrated potential in alleviating suicidal ideation, providing a lifeline to individuals experiencing the darkest moments of depression. However, if you are having active suicidal ideation, please do not wait - go to your nearest emergency room or mental health provider.
Lumin Health Locations
Newton Centre
10 Langley Road, Suite 200
Newton, MA 02459Cambridge (Harvard Square)
50 Church Street, 3rd Floor
Cambridge, MA 02138Woburn
300 Tradecenter Drive, Suite 3400
Woburn, MA 01801Brookline
1101 Beacon Street, Suite 4E
Brookline, MA 02446Bethesda
4825 Bethesda Avenue
Suite 200
Bethesda, MD 20814
10 Langley Road, Suite 200
Newton, MA 02459Cambridge (Harvard Square)
50 Church Street, 3rd Floor
Cambridge, MA 02138Woburn
300 Tradecenter Drive, Suite 3400
Woburn, MA 01801Brookline
1101 Beacon Street, Suite 4E
Brookline, MA 02446Bethesda
4825 Bethesda Avenue
Suite 200
Bethesda, MD 20814
Monday - Friday, 8am - 6pm
Contact
